- Before
- “I find out what changed in September when I write the report in October.”
- Now
- Sees the theme the Monday it doubles, with the notes behind it; decides each theme and sends its actions to their owners.
One theme, from a Monday alert to a signed report
Northwind Bio's Immunology team runs medical affairs for Veltrimab. On Monday 6 October the scan finds that questions about patients over 65 have doubled in four weeks. Here is what happens next, screen by screen, in the working solution.
- 01Monday 06:00
The theme that doubled, on the map she opens first
Priya Raman · Medical insights leadPriya's home is a map of 12 themes: each bubble sized by mentions from 7 September to 4 October and coloured by the change on the four weeks before. The Monday scan read 187 new insights. T-07, “Patients over 65: dosing and infection risk”, went from 48 to 99 mentions, +106%, and the alert is sourced to 9 MSL notes in 3 countries — United States 4, Germany 3, Japan 2.
“Give me serious infection rates for over-65s on steroids and I will decide case by case.” — Illinois, United States · Emily Carter · Oct 1
- 02The theme
Four agents built the theme in 9.6 seconds
The agentsInsight intake brought in 174 insights from 5 channels with the HCPs de-identified. The insight coder coded them and flagged 2 follow-up requests for medical information. The theme clusterer found 4 sub-themes, +160% on Q2, and wrote the statement with 5 citations; the evidence and plan linker matched gap EG-14 and objective MPO-3 and proposed 4 actions. Each citation number in the statement opens the insight behind it.
“Community gastroenterologists, mostly in the US Midwest, Germany and Japan, hesitate to start Veltrimab in patients over 65: published results do not report infection rates for that age group separately, and they ask whether the dose should change with age, kidney function or frailty.”
- 03The proposal
Four actions, each with an owner, and her decision
Evidence and plan linkerThe linker proposes a pooled safety analysis of patients 65 and over from VLT-302, VLT-305 and the extension (Omar Haddad, due Jan 30), an MSL slide module on treating older adults (Lena Ortiz, Nov 15), an update to standard response SRL-0412 (Sam Patel, Oct 31) and two questions for the Q4 HCP survey (Priya Raman, Nov 3). The agents suggest a key insight at 91% confidence; the choice is hers.
Her options: promote to key insight · keep watching · merge with another theme · not a theme.
- 04One click
Promoted to a key insight, with a note for leadership
Priya Raman · Medical insights leadThe theme becomes a key insight in the Q3 report and the four actions go to their owners. Priya adds a note for the medical leadership team. The 212 patients aged 65 and over already in the trials mean the question can be answered from data on file.
“Raised in Q2; doubled this quarter. The pooled analysis can answer it from data we already hold.”
- 05Minutes later
The badge on the map names the next owner
Priya Raman · Medical insights leadOn the map the T-07 badge changes from “!” — waiting for her decision — to SP. Sam Patel owns the next step: update standard response SRL-0412 on use in older patients, due Oct 31. The panel keeps what was already done: EG-14 logged in Q2 with its priority raised to high, and Jonas Weber's physician question on infections by age band sent to medical information as request MIR-2026-08812.
“Key insight · 4 actions sent to their owners · recorded in the audit trail”
- 06Before 17:00
A physician's question waits for a written answer
Insight coderOne insight in the theme, INS-30871 from Emily Carter in Wisconsin, records a question she could not answer in the meeting: should shingles vaccination be completed before the first dose in patients over 75? The physician asked for a written response. The insight coder drafted the request to medical information with the passage highlighted; the physician's contact stays in the CRM. Priya confirms the request before 17:00.
“Medical information answers it; the request goes within one business day.”
- 07About a minute
The Q3 report, every sentence cited
Report writerPriya presses “Draft the report”. The report writer works from her decisions: 2,946 insights, 13% more than Q2, grouped into 12 themes, with the over-65 theme first and a recommendation that the leadership team endorse the pooled safety analysis. The draft carries 25 citations, and the two themes she has not decided appear as “for discussion”.
The report writer never writes a sentence without a citation.
- 08Brand version
What brand teams may see, with every removal listed
Firewall guardThe firewall guard builds the brand version from sharing rules v3 and lists four removals: theme T-11, an unapproved use that stays medical-only; HCP detail, with city and practice dropped; 2 small region cells folded into “Other”; and medical information request detail. Nothing reaches the brand team before Dana Okafor approves it.
Fails closed: an item it cannot classify is removed.
- 09Signed
Governance approves; the medical director signs
Dana Okafor and Dr. Maya ChenPriya sends the report for sign-off. Dana Okafor, medical governance, approves the brand version. Dr. Maya Chen, TA medical director, signs with the meaning of her signature, and the report is shared with the medical leadership team — the medical version, and the brand version for the brand team.
Meaning: “I approve this report for the medical leadership team.”